PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment

Clinical trial NCT02864030 · COMPLETED

Trial details

NCT number: NCT02864030
Sponsor: Oncologia Medica dell'Ospedale Fatebenefratelli
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Metastatic Breast Cancer Toxicity Neurotoxicity Drug Toxicity Adverse Drug Event

Start date: 2014-05-01
Primary completion: 2018-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.